ResearcherIran University of Medical SciencesActive in the last 2 years

Mahshid Panahi

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-8005-3273; OpenAlex author ID A5082724795. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2023: 1 paper · 2024: none · 2025: 1 paper

Papers 2

Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated progression from pancreatic intraepitheli… Co-author DOI 10.1186/s12935-025-03810-1 ↗
The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic adenocarcinoma. Co-author DOI 10.1016/j.ctarc.2023.100699 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Fereshteh Rezagholizadeh · 2 shared papers, 2023–2025 · strength 0.42
- Paper Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated p… DOI 10.1186/s12935-025-03810-1 ↗
- Paper The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic ad… DOI 10.1016/j.ctarc.2023.100699 ↗
Mohammad Taghi Joghataei · 1 shared paper, 2025 · strength 0.22
- Paper Transcriptomic analysis of laser-capture microdissected tumors reveals RAD51AP1 as a tumor-specific marker associated p… DOI 10.1186/s12935-025-03810-1 ↗
Pooya Farhangnia · 1 shared paper, 2023 · strength 0.19
- Paper The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic ad… DOI 10.1016/j.ctarc.2023.100699 ↗
Seyed Mohammad Heshmati · 1 shared paper, 2023 · strength 0.19
- Paper The association between CD3+ and CD8+tumor-infiltrating lymphocytes (TILs) and prognosis in patients with pancreatic ad… DOI 10.1016/j.ctarc.2023.100699 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.